Transmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in South East Asia.
about
Prevalence of Primary HIV Drug Resistance in Thailand Detected by Short Reverse Transcriptase Genotypic Resistance AssayNovel Approaches for Visualizing and Analyzing Dose-Timing Data from Electronic Drug Monitors, or "How the 'Broken Window' Theory Pertains to ART Adherence".Factors associated with suboptimal adherence to antiretroviral therapy in Asia.A Comparison of Seven Cox Regression-Based Models to Account for Heterogeneity Across Multiple HIV Treatment Cohorts in Latin America and the CaribbeanEffects of unplanned treatment interruptions on HIV treatment failure - results from TAHODPrevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013.Pre-treatment minority HIV-1 drug resistance mutations and long term virological outcomes: is prediction possible?Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children.Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.The occurrence of Simpson's paradox if site-level effect was ignored in the TREAT Asia HIV Observational Database.The impact of antiretroviral therapy in resource-limited settings and current HIV therapeutics.Pretreatment HIV-1 drug resistance to first-line drugs: results from a baseline assessment of a large cohort initiating ART in Vietnam, 2009-10.Long term impact of antiretroviral therapy--can we end HIV epidemic, the goal beyond 2015.The World Health Organization's Response to Emerging Human Immunodeficiency Virus Drug Resistance and a Call for Global Action.Prevalence of Transmitted HIV drug resistance in antiretroviral treatment naïve newly diagnosed individuals in China
P2860
Q28553024-C21EF8AD-755E-4E3E-ADAD-2A1F98A54338Q30936928-58919A3D-CD8D-4DD7-BC8F-70408187681DQ33626312-E972D867-75A1-421B-AE2B-F1E497BA1386Q35589775-C1665593-A187-494F-BC52-F833DEF93632Q35948083-98A4B3C8-4024-4DA8-8FC8-D00D32968E65Q36460056-F5D259DE-2BEC-4973-931B-642A410E7FAFQ37336600-588547CC-044A-4C0B-B13D-76D7ADEC21BAQ38849814-DC5B575C-CE0F-4AAC-9847-87557C8CB6C9Q38858252-66265725-AE8D-48E2-A47E-36AC89E42A86Q38911057-39DEF901-6BA9-472E-9F95-1C139796D9C4Q40701264-FCD49C46-2FC7-4752-BDD6-080B469E53DFQ41644248-2230A756-DA39-41D4-838A-ED22EB2DF41CQ43193306-56F39E39-7036-4D9C-8DC6-6FA5FEEA6B37Q45326203-786C6549-9639-43D4-AD63-0F0B179B2168Q58774654-4443A127-8A6B-4F4E-8E22-ECA54457CF1A
P2860
Transmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in South East Asia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Transmitted drug resistance an ...... d patients in South East Asia.
@ast
Transmitted drug resistance an ...... d patients in South East Asia.
@en
type
label
Transmitted drug resistance an ...... d patients in South East Asia.
@ast
Transmitted drug resistance an ...... d patients in South East Asia.
@en
prefLabel
Transmitted drug resistance an ...... d patients in South East Asia.
@ast
Transmitted drug resistance an ...... d patients in South East Asia.
@en
P2093
P2860
P50
P1476
Transmitted drug resistance an ...... d patients in South East Asia.
@en
P2093
Awachana Jiamsakul
Christopher Lee
Mahiran Mustafa
Man Po Lee
Pacharee Kantipong
Praphan Phanuphak
Rami Kantor
Rossana Ditangco
Sunee Sirivichayakul
Thida Singtoroj
P2860
P356
10.1097/QAI.0000000000000108
P407
P577
2014-05-01T00:00:00Z